Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You are browsing as a GUEST

You search for a phrase ""Chinot O"" according to the criterion: Author


Title :
High-grade glioma in elderly patients: can the oncogeriatrician help?
Authors :
Tabouret E
Tassy L
Chinot O
Crétel E
Retornaz F
Rousseau F
Show more
Subject Terms :
brain tumor
older cancer patient
chemotherapy toxicity
oncogeriatric charter
Geriatrics
RC952-954.6
Source :
Clinical Interventions in Aging, Vol Volume 8, Pp 1617-1624 (2013)
File Description :
electronic resource
Relation :
https://www.dovepress.com/high-grade-glioma-in-elderly-patients-can-the-oncogeriatrician-help-peer-reviewed-article-CIA; https://doaj.org/toc/1178-1998
Access URL :
https://doaj.org/article/79a63ad12ea7411f99c295d6d9f55052
Academic Journal
Title :
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study
Authors :
Ursu, R.
Thomas, L.
Psimaras, D.
Chinot, O.
Le Rhun, E.
Ricard, D.
Charissoux, M.
Cuzzubbo, S.
Sejalon, F.
Quillien, V.
Hoang-Xuan, K.
Ducray, F.
Portal, J.-J.
Tibi, A.
Mandonnet, E.
Levy-Piedbois, C.
Vicaut, E.
Carpentier, A.F.
Show more
Subject Terms :
[PHYS]Physics [physics]
Source :
Eur.J.Cancer, 2019, 109, pp.129-136. ⟨10.1016/j.ejca.2018.12.025⟩
Title :
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study
Authors :
Ursu, R.
Thomas, L.
Psimaras, D.
Chinot, O.
Le Rhun, E.
Ricard, D.
Charissoux, M.
Cuzzubbo, S.
Sejalon, F.
Quillien, V.
Hoang-Xuan, K.
Ducray, F.
Portal, J.-J.
Tibi, A.
Mandonnet, E.
Levy-Piedbois, C.
Vicaut, E.
Carpentier, A.F.
Show more
Subject Terms :
[PHYS]Physics [physics]
Source :
Eur.J.Cancer, 2019, 109, pp.129-136. ⟨10.1016/j.ejca.2018.12.025⟩
Title :
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study
Authors :
Ursu, R.
Thomas, L.
Psimaras, D.
Chinot, O.
Le Rhun, E.
Ricard, D.
Charissoux, M.
Cuzzubbo, S.
Sejalon, F.
Quillien, V.
Hoang-Xuan, K.
Ducray, F.
Portal, J.-J.
Tibi, A.
Mandonnet, E.
Levy-Piedbois, C.
Vicaut, E.
Carpentier, A.F.
Show more
Subject Terms :
[PHYS]Physics [physics]
Source :
Eur.J.Cancer, 2019, 109, pp.129-136. ⟨10.1016/j.ejca.2018.12.025⟩
Title :
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study
Authors :
Ursu, R.
Thomas, L.
Psimaras, D.
Chinot, O.
Le Rhun, E.
Ricard, D.
Charissoux, M.
Cuzzubbo, S.
Sejalon, F.
Quillien, V.
Hoang-Xuan, K.
Ducray, F.
Portal, J.-J.
Tibi, A.
Mandonnet, E.
Levy-Piedbois, C.
Vicaut, E.
Carpentier, A.F.
Show more
Subject Terms :
[PHYS]Physics [physics]
Source :
Eur.J.Cancer, 2019, 109, pp.129-136. ⟨10.1016/j.ejca.2018.12.025⟩
Title :
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study
Authors :
Ursu, R.
Thomas, L.
Psimaras, D.
Chinot, O.
Le Rhun, E.
Ricard, D.
Charissoux, M.
Cuzzubbo, S.
Sejalon, F.
Quillien, V.
Hoang-Xuan, K.
Ducray, F.
Portal, J.-J.
Tibi, A.
Mandonnet, E.
Levy-Piedbois, C.
Vicaut, E.
Carpentier, A.F.
Show more
Subject Terms :
[PHYS]Physics [physics]
Source :
Eur.J.Cancer, 2019, 109, pp.129-136. ⟨10.1016/j.ejca.2018.12.025⟩
Title :
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study
Authors :
Ursu, R.
Thomas, L.
Psimaras, D.
Chinot, O.
Le Rhun, E.
Ricard, D.
Charissoux, M.
Cuzzubbo, S.
Sejalon, F.
Quillien, V.
Hoang-Xuan, K.
Ducray, F.
Portal, J.-J.
Tibi, A.
Mandonnet, E.
Levy-Piedbois, C.
Vicaut, E.
Carpentier, A.F.
Show more
Subject Terms :
[PHYS]Physics [physics]
Source :
Eur.J.Cancer, 2019, 109, pp.129-136. ⟨10.1016/j.ejca.2018.12.025⟩
Title :
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma
Authors :
Ellingson, BM
Abrey, LE
Nelson, SJ
Kaufmann, TJ
Garcia, J
Chinot, O
Saran, F
Nishikawa, R
Henriksson, R
Mason, WP
Wick, W
Butowski, N
Ligon, KL
Gerstner, ER
Colman, H
de Groot, J
Chang, S
Mellinghoff, I
Young, RJ
Alexander, BM
Colen, R
Taylor, JW
Arrillaga-Romany, I
Mehta, A
Huang, RY
Pope, WB
Reardon, D
Batchelor, T
Prados, M
Galanis, E
Wen, PY
Cloughesy, TF
Show more
Subject Terms :
bevacizumab
clinical trials
contrast-enhancing tumor volume
GBM
new glioblastoma
prognosis
T1 subtraction
Source :
Ellingson, BM; Abrey, LE; Nelson, SJ; Kaufmann, TJ; Garcia, J; Chinot, O; et al.(2018). Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. NEURO-ONCOLOGY, 20(9), 1240 - 1250. doi: 10.1093/neuonc/noy053. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0v78z01z
File Description :
application/pdf

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.